Dow Up 0.48% Nasdaq Up 0.43%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.20 0.04(3.23%) Aug 19, 4:00PM EDT
Prev Close:1.24
Open:1.24
Bid:1.21 x 800
Ask:1.50 x 3000
1y Target Est:3.10
Beta:1.89
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.19 - 1.26
52wk Range:1.19 - 5.19
Volume:2,898,786
Avg Vol (3m):2,512,750
Market Cap:169.25M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXDown 3.23%169.25M
AZN89.07B
GSK113.73B
PFE183.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback